Clinical cardiology

Antiplatelet Therapy: When the Evidence Meets the Experience

Oct 1, 2008 10:15 EDT

The optimal management of patients with ACS is an ever-evolving process; clinical experience and practice often outpace guidelines. Watch Drs Bohm, Camm, Fox, Mehta, and Connolly address the state-of-the-art management of ACS and the role of antiplatelets in ACS and beyond.

Clinical cardiology

ICD Therapy: New Data on Quality of Life and Outcomes

Sep 10, 2008 11:00 EDT

New data on quality of life and long-term prognosis after ICD implantation for primary prevention was recently published in the New England Journal of Medicine. Join Drs Bhatt, Harrington, and Prystowsky as they review this new data and discuss the clinical context of these studies.

Arrhythmia/EP

Improving Cardiovascular Outcomes in AF

2 COMMENTS - Sep 3, 2008 14:00 EDT

For all the debates on rate vs rhythm control, contemporary analyses show little change in atrial fibrillation (AF) mortality rates in the past 20 years. Will recent developments, including novel pharmacologic agents and advances in catheter ablation, translate into meaningful clinical benefit for patients? Drs Camm, Falk, Knecht, and Hohnloser each give presentations on key issues relating to the contemporary management of patients with AF.

Arrhythmia/EP

Stroke in Pharmacologically-Managed AF

1 COMMENT - Sep 3, 2008 14:00 EDT

The rate vs rhythm AF trials suggest that rhythm-managed AF patients experience more strokes possibly due to cessation of warfarin in patients with unrecognized, asymptomatic AF. Stuart Connolly presents the ESC late-breaking ATHENA findings that challenge this viewpoint and Drs Fox, Dorian, and Steg discuss the implications and possible mechanisms.

Acute Coronary Syndrome

The Science and Medicine of Circulatory Dysfunction and Acute Pressure Syndromes

Aug 18, 2008 09:37 EDT

An investigator and clinical scholar, Dr. Christopher Granger, MD, the program chairman, and his distinguished colleagues illuminate the emerging threats and clinical challenges cardiologists face when managing patients who present with, or undergo, acute, severe, serious, precipitous, and/or life-threatening elevations in systemic blood pressure.

Clinical cardiology

Utilization of ICD therapy: The current state of the industry

5 COMMENTS - Jun 27, 2008 10:58 EDT

Dr Eric N Prystowsky MD discusses the current utilization of ICD guidelines and strategies to improve patient care.

Clinical cardiology

Current trends in cardiac resynchronization therapy

3 COMMENTS - Jun 27, 2008 09:49 EDT

Join Drs Linde, Daubert and Gold in an intriguing discussion on the impact of cardiac resynchronization therapy on remodeling and disease progression, with a review of new data by Dr Abraham.

Clinical cardiology

Thienopyridines in PCI: The lowdown on loading doses

Jun 23, 2008 11:00 EDT

Current guidelines for thienopyridines in PCI note the lack of RCT data for higher loading doses. Read Dr Wang's lowdown on loading doses, including recent presentations from the 2008 SCAI-ACCi2 meeting. Then watch Drs Mehta and Mehran discuss where CURRENT-OASIS-7 will fit in.

Arrhythmia/EP

Pioneering the future: Innovations and strategies in electrophysiology and clinical cardiology

May 27, 2008 11:30 EDT

Drs Lindsay, Brugada, Gold and Stein highlight the most recent clinical trial data demonstrating the efficacy and safety of ICDs and cardiac resynchronization therapy (CRT) devices and their potential impact on clinical practice.

Clinical cardiology

Lost in translation: US and European guidelines for the pharmacologic management of ACS

5 COMMENTS - Apr 10, 2008 14:00 EDT

If we're all looking at the same data, why do the European and US guidelines for the treatment of ACS differ in terms of initiation, dosing, and choices of pharmacological therapies? Drs Ohman, Montalescot, Pollack and Fox discuss the similarities and differences.

Clinical cardiology

Antiplatelet therapy for atherothrombotic disease: Translating the evidence from clinical trial into practice

1 COMMENT - Feb 29, 2008 10:54 EST

This program will review the guidelines recommendations for and actual use of antiplatelet therapy in patients with atherothrombotic disease, practical issues in the use of antiplatelet therapy, and new trials of antiplatelet agents

Clinical cardiology

Recent clinical trial data on adjunctive pharmacology in ACS patients undergoing PCI

Dec 27, 2007 12:30 EST

What is the future of adjunctive pharmacology given the results of the HORIZONS and TRITON trials?

Clinical cardiology

Risk/benefit or benefit/risk: Trading safety for efficacy with antiplatelet agents

1 COMMENT - Dec 20, 2007 18:00 EST

Trading safety for efficacy with antiplatelet agents

Clinical cardiology

Antiplatelet Therapy Across the Cardiovascular Risk Spectrum

Nov 26, 2007 10:00 EST

Drs Berger, Faxon and Steinhubl sddress clinical challenges in the management of patients with suspected ACS/ST-elevation myocardial infarction and cecognize the clinical implications of variability in response to antiplatelet agents.

Clinical cardiology

PCI Today: Insights into Short and Long-Term Risk Reduction With Antiplatelet Therapy

Nov 8, 2007 13:30 EST

Are you aware of the latest guidelines, definitions and best practices? Straight from TCT 2007: Drs Grines, Cannon, Cutlip, and Mehta address gaps in current practice, explain challenges in the use of antiplatelet therapy, and discuss recently released definitions and guidelines for care.

Clinical cardiology

Managing atherothrombotic risk: Early impact and long-term benefit of antiplatelet therapy

Oct 9, 2007 11:45 EDT

This program delivers evidence-based education, debate on the issues, data from randomized trials, observational data, and objective opinions from leaders in cardiology on the subject of antiplatelet therapies and their appropriate use in atherothrombosis.

Clinical cardiology

Update on combination antiplatelet therapy

Jul 31, 2007 09:30 EDT

This program discusses the optimal use of combination antiplatelet therapy in non-ST elevation ACS, both in the acute and long-term setting. Additionally, the program will touch upon the early use of combination antiplatelet therapy in the setting of STEMI. Referencing the recent joint statement on DES by the Canadian Association of Interventional Cardiologists and the Canadian Cardiovascular Society, the program will also discuss optimal duration of dual antiplatelet therapy, strategies to prevent early discontinuation, and potential management strategies for patients who may require surgery while on dual antiplatelet therapy.

Clinical cardiology

Looking Forward: Acute and Long-Term Antiplatelet Therapies

Apr 10, 2007 16:00 EDT

Antiplatelet therapy is the mainstay of comprehensive care for a broad spectrum of patients with atherothrombotic disease. Join Dr. Peter Berger as he leads an expert multidisciplinary panel of Drs. Ferguson, Pollack, and Simon in discussing case studies involving acute and long-term antiplatelet therapies.

Acute coronary syndromes

Antithrombotic therapy in STEMI: What happened at AHA 2006?

Nov 27, 2006 10:00 EST

What is the ideal antithrombotic therapy for the management of STEMI patients? Please join Dr Antman and an expert panel as they discuss the latest clinical trial data from the AHA 2006 Scientific Sessions regarding the management of STEMI patients.

	Interactive cases
	Downloadable slides
	BLOG with experts in your area of interest
	Information addressing clinical practice issues